GE Healthcare

Spect-CT 800 Series

GE Healthcare Series 800

All our new 800 Series SPECT/CT systems build on the success of the 600 Series with a collection of SPECT technology enhancements that add to the value of nuclear medicine. In addition to the all-new SmartConsole, these enhancements include a new LEHRS (Low Energy High Resolution and Sensitivity) collimator, which can be combined with either SPECT Step & Shoot Continuous scanning mode or our Planar Clarity 2D processing to increase sensitivity and enable a reduction of scan times or injected dose. It’s called SwiftScan Planar and SwiftScan SPECT.


One Serie, upgradability, compatibility

Spect-CT 870 CZT

Super High-end Spect-CT

Higher count rate, SmartMAR, 32 slides, iterative reconstruction ASIR,… 

CZT is the key component to the future of nuclear medicine. Not only is it lighter and more compact than the Nal crystals used in analog technology, it is pixelated. Each detector head consists of 130 CZT detector modules, which means there are tens of thousands of tiny 2.46 mm-sized pixels capturing events independently, all via direct conversion. With CZT and registered collimation, each photon is directly converted into an electrical signal that more accurately identifies its location and energy. This design reduces the signal loss and noise inherent in conventional SPECT detection by eliminating gamma photon conversion through scintillation and light conversion through PMT. The result is increased spatial and energy resolution.

NM/CT 870 CZT is the third-generation of our general purpose digital SPECT/CT system designed with this breakthrough CZT detection technology. Combined with the latest Xeleris quantitative applications and CT advancements that include a 32-slice overlapped reconstruction capability, the latest dose reduction technologies and Smart MAR, this system will transform your entire nuclear medicine experience.

Digital CZT Detectors Revolition has just begun

  • Up to 75 percent reduction in injected dose or scan time2
  • Improved system spatial resolution, from 4.3 mm to 2.8 mm3
  • Exceptional energy resolution, 6.3 percent compared to 9.5 percent
  • Greater than 40 percent improvement in SPECT contrast-to-noise ratio4
  • 67 percent reduction in detector frame size, from 7.5 cm to 2.5 cm
  • 25 percent greater optimal FOV than Nal
  • 1.4 times higher count rates than conventional technology
  • Up to 50 percent reduction in injected dose or scan time with Evolution technology5
  • Leverage advanced CT dose reduction technology with ASiR™,6
  • Maintain quantitative SPECT accuracy when corrected by low-dose CT with Q.AC7
  • Smart MAR helps reduce photon starvation, beam hardening and streak artifacts caused by metal in the body, such as hip implants
  • Platform compatible with advanced digital solutions designed to connect machines, people and data throughout a portfolio of healthcare analytics applications



Xeleris 4 DR is leading the way from relative to absolute quantitation in nuclear medicine with the numerical values referring physicians demand to strengthen the quality of your nuclear medicine reports. Until now, the quantitative value of nuclear medicine was limited by the technology used to produce it. By leveraging our next-generation camera technology, we developed a collection of simplified tools that combine relative and absolute quantitation.

  • Effortless quantitative tracer uptake across any lesion or organ with Q.Volumetrix MI
  • Accurately diagnose neurodegenerative diseases with Q.Brain
  • Diagnose pulmonary embolism by identifying V/Q mismatch with Q.Lung
  • Confidently classify patients eligible for lung resection surgeries with Q.Lung
  • Leverage the power of CZT to calculate blood flow measurements with Alcyone CFR
  • Improve neurologic SPECT workflow with fast, reproducible and accurate quantitation of 123I-loflupane SPECT data with DaTQUANTTM
  • Plan radioisotope therapy by measuring changes in tracer absorption over time with Dosimetry Toolkit

More details available on GE Healthcare website –